De novo thrombus on an atrial septal defect device 3 years after its implantation

Olawale O Olabiyi1, David L S Morales, Wayne J Franklin

  • 1The Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, 6221 Fannin St MC-19345-C, Houston, TX 77030, USA. olabiyi@bcm.edu

Pediatric Cardiology
|June 20, 2012
PubMed

Insights

Percutaneous closure of secundum atrial septal defects (ASD) can lead to rare, late complications. This case highlights device thrombus as a very late complication after ASD closure.

Area of Science:

  • Cardiology
  • Medical Devices
  • Congenital Heart Disease

Background:

  • Secundum atrial septal defect (ASD) is a common congenital heart defect (CHD), occurring in 1 in 1,500 live births.
  • Percutaneous closure is a standard treatment for secundum ASDs.
  • Early complications include device issues, arrhythmias, and thrombus formation.

Observation:

  • This report details a patient experiencing a very late complication following percutaneous closure of a secundum ASD.

Findings:

  • The patient developed device thrombus, a rare but significant late complication.
  • This finding underscores the potential for delayed adverse events after ASD device closure.

Implications:

  • Awareness of very late complications like device thrombus is crucial for long-term patient management.
  • Further research may be needed to understand the mechanisms and prevention of late-onset device-related thrombosis.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...